کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
3946607 1254348 2006 9 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Psammoma bodies in cervicovaginal cytology specimens: A clinicopathological analysis of 31 cases
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی زنان، زایمان و بهداشت زنان
پیش نمایش صفحه اول مقاله
Psammoma bodies in cervicovaginal cytology specimens: A clinicopathological analysis of 31 cases
چکیده انگلیسی

Background.Psammoma bodies in cervicovaginal cytology specimens are associated with malignant and benign conditions. Few studies have evaluated which features distinguish patients with underlying malignancy from those with benign conditions.Methods.Pathology files were searched for cervicovaginal specimens having psammoma bodies. The cytology specimen was assessed for the background, glandular atypia, squamous atypia, and presence of non-psammomatous calcifications. Clinical data was obtained from chart review.Results.Nineteen women (mean age 42.7 years) had benign outcomes. None had signs or symptoms suggesting malignancy. None had highly atypical or malignant appearing glandular cells. Twelve women had malignant neoplasms (mean age 56 years), including 6 with recurrent disease. Four women without prior malignancy had worrisome signs including bleeding or mass. All six women with prior malignancy had signs of recurrent disease. All specimens contained highly atypical or malignant glandular cells.Conclusions.The only cytologic feature predictive of outcome was the presence of highly atypical gladular cells in the specimen (P = 0.001), but these cells may be few. Women with underlying malignancy were older than those with benign outcome (P = 0.014) and more likely to be postmenopausal (P = 0.05). Women with malignancy had signs that warranted additional investigation whereas those with benign outcome were usually asymptomic (P = 0.001).

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Gynecologic Oncology - Volume 103, Issue 1, October 2006, Pages 238–246
نویسندگان
, , , , ,